Bone mineral density reduction and long term use of inhaled corticosteroids Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008
Effects of long term used inhaled corticosteroids on growth and bone mineral density in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
Long-term effects of corticosteroid use on bone mineral density in asthmatic children Source: Breathe 2008; 5: 70-71 Year: 2008
Peak bone mineral density (BMD) in children with asthma treated for a mean of 14 years with inhaled budesonide Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Bone mineral density and inhaled budesonide – a systematic review of long-term treatment in children and adults Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005
Effect of inhaled fluticasone poprionate and repeated short courses of oral corticosteroid on bone turnover in asthmatic children Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008
Prospective follow-up of novel bone turnover markers in asthmatics exposed to low or high doses of inhaled ciclesonide over 1 year Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012
Lack of association between inhaled corticosteroids and bone density in postmenopausal women Source: Eur Respir J 2001; 18: Suppl. 33, 442s Year: 2001
The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Continuity study of the bone mineral density reduction in long term use of inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015
The influence of high dose beclomethasone dipropionate (BDP) on bone density in perimenopausal women with bronchial asthma (BA) Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002
Inhaled corticosteroids (ICS) and bone mineral density (BMD) - a follow-up study. The bronchial obstruction in Nord-Trøndelag study (BONT) Source: Eur Respir J 2004; 24: Suppl. 48, 601s Year: 2004
Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients Source: Annual Congress 2009 - New drugs for airways disease Year: 2009
Morning cortizolemia and bone status during long term therapy with inhaled steroids in children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Is there a risk of bone fracture in asthmatic children treated with inhaled ICS? Source: ISSN=ISSN 1810-6838, ISBN=, page=244 Year: 2005
Relationship between structural bone changes assessed by ultrasound bone densitometry (UBD) and growth hormone (GH) during chronic treatment with inhaled corticosteroids (ICS) in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003
Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001
High doses of inhaled formoterol have less systemic effect in asthmatic children than high doses of inhaled terbutaline Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003